Effectiveness and safety of rivaroxaban versus warfarin in Taiwanese patients with end-stage renal disease and nonvalvular atrial fibrillation: A real-world nationwide cohort study

BACKGROUND: The optimal anticoagulant for end-stage renal disease patients for stroke prophylaxis is unknown. The efficacy and safety of warfarin in this population are debatable. In addition, real-world evidence of direct oral anticoagulants in patients with end-stage renal disease is limited. The...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS One
Main Authors: Lin, Yi-Cheng, Chen, Bi-Li, Shih, Chun-Ming, Lin, Feng-Yen, Chen, Chih-Wei, Hsu, Chien-Yi, Kao, Yung-Ta, Bi, Wei-Fung, Chen, Li-Ying, Chien, Li-Nien, Fang, Te-Chao, Huang, Chun-Yao
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2021
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8031437/
https://ncbi.nlm.nih.gov/pubmed/33831130
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0249940
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados